As the name suggests (Neuro= nervous, endocrinal= hormonal), neuroendocrine tumors occur when there is an abnormal and excessive growth in tissues or neoplasm in neuroendocrine cells. These cells work as a bridge between the nervous and the endocrinal system. They receive the signal (neurotransmitters) from the neurons (nerve cells) and accordingly produce the relevant hormone. Thus, these cells are responsible for basic day-to-day functions such as eating behavior, metabolism, and reproduction. Neuroendocrine tumors can be benign or carcinogenic and can affect any part of the body. There are numerous kinds of neuroendocrine tumors; however, they are considered as a group of tissue since the cells of these tumors have common characteristics such as they look similar, they have unique secretory granules, and they generate polypeptide hormones and biogenic amines frequently.
Neuroendocrine Tumors Treatment Market Overview
According to a study conducted by the U.S. National Library of Medicine and American Cancer Society, the proportion of occurrence of neuroendocrine tumor increased from 2.48 to 5.86 during 2009–2010, in a population sample size of 1 lakh, (roughly 136% jump). According to the same study, the increase in number of neuroendocrine tumors may be a result of increased detection. The occurrences of neuroendocrine tumors have increased manifold over last 15 years. Owing to technological developments as well as early detection techniques, the 5-year survival rate of neuroendocrine tumors has increased in recent years. Consequently, the proportion of the population with neuroendocrine tumors opting for treatment have risen, given its high success rate. This is projected drive growth of the neuroendocrine tumor treatment market in the near future.
Neuroendocrine Tumors Treatment Market Taxonomy
On the basis anatomic distribution, neuroendocrine tumors treatment market is classified into:
On the basis of treatment, the global neuroendocrine tumors treatment market is classified into:
On the basis of type of end user, the global neuroendocrine tumors treatment market is classified into:
As per the World Health Organization, neuroendocrine tumors have been classified into three broad categories. They are well-differentiated neuroendocrine tumors, well-differentiated (low grade) neuroendocrine carcinomas, and poorly differentiated (high grade) neuroendocrine carcinomas. According to a report by National Center for Biotechnology Information (NCBI), neuroendocrine tumors are second-most prevalent gastrointestinal tumors in the U.S. However, pancreatic neuroendocrine tumor is the most common type of neuroendocrine tumor in the Asia Pacific region. As per Expert Rev Endocrinal Matlab, localized neuroendocrine tumors have grown many folds in the last two decades. Additionally, Surveillance, Epidemiology, and End Results (SEER) program survey data suggests that the incidence of malignant neuroendocrine tumors is increasing.
Technological advancements and early detection increasing revenue potential of neuroendocrine tumors market
Early detection is key to survival for neuroendocrine tumor. The survival rate as well as survival duration in patients diagnosed in Stage I are much more than patients who are diagnosed late. Moreover, latest advancements such as radiation therapy under which, targeted radiation therapy and external beam radiation therapy are highly effective when compared to usual medication. This have significantly increased effectiveness of neuroendocrine tumors treatment and diagnosis. Increasing awareness about effective treatment option for the ailment is another factor that would drive market growth in the future. Globally, patients and doctors alike have become more conscious about their health and economic burden of medical conditions have risen substantially. Earlier, medical checkups were a rare phenomenon. However, in the present global scenario, the percentage of medical checkups have increased significantly, which creates a favorable environment for growth of the neuroendocrine tumors treatment market. As the number of diagnosed patient increases, the rate of survival increases proportionally, this in turn will help in the growth of neuroendocrine tumors market over the forecast period (2016–2024).
Lutate emerging as a preferred drug in the Neuroendocrine Tumors Treatment Market
Hospitals remain the most potential avenue for investment for neuroendocrine tumors treatment market. The treatment needs critical care and strict supervision by the physician, which makes treatment in other facilities fairly tough. Moreover, surgeries are the most common treatment for neuroendocrine tumors, especially in the latter stages. Therefore, patients diagnosed with neuroendocrine tumors invariably choose hospitals for their treatment. However, apart from surgery, lutate is gaining prominence in the neuroendocrine treatment market. This is a new form of treatment that can be used if surgery, chemotherapy, radiation therapy proves to be ineffective. Lutate is the name of a drug that works by using radioactive particles and internally targets the infected cells/ tissue.
Major Players in the Neuroendocrine Tumors Treatment Market
Some of the companies that manufacture Lutate are Advanced Accelerator Applications and Lutate SL. Other major players in the neuroendocrine tumors treatment market include F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Ltd., Eli Lilly & Company, Amgen, Inc., Ispen SA, Callisto Pharmaceuticals Pvt. Ltd., Bristol-Myers Squibb, Teva Pharmaceuticals, Ltd. and Biosynthema,
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.